Evidence map›Paper›PMID 32350653›Full record

ArticleEuropean journal of nutrition2021

Alleviation effects of Bifidobacterium breve on DSS-induced colitis depends on intestinal tract barrier maintenance and gut microbiota modulation.

Yang Chen, Yan Jin, Catherine Stanton, R Paul Ross, Jianxin Zhao, Hao Zhang, Bo Yang, Wei Chen

Abstract read
PubMed Publisher
In one paragraph

Article in European journal of nutrition, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 47 papers.

0numbers the graph read from it
0cells of the map it votes in
47citing papers in PubMed
4.0field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

47 citing papers in PubMed, 101 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. Review
  5. Preventive Effects of Probiotic and PostbioticJournal of microbiology and biotechnology · 2026
    Article
  6. Article
  7. Gut microbes · 2025
    Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Heat-killedJournal of clinical biochemistry and nutrition · 2025
    Article
  13. Article
  14. In Vitro Assessment ofInternational journal of molecular sciences · 2025
    Article
  15. Review
  16. Review
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 2 countries.

Yang ChenState Key Laboratory of Food Science and Technology, Jiangnan University, Wuxi, Jiangsu, China.
Yan JinDepartment of Gastroenterology, The Affiliated Wuxi Second People's Hospital of Nanjing Medical University, Wuxi, Jiangsu, China. 13951514799@163.com.
Catherine StantonInternational Joint Research Center for Probiotics and Gut Health, Jiangnan University, Wuxi, Jiangsu, China.
R Paul RossInternational Joint Research Center for Probiotics and Gut Health, Jiangnan University, Wuxi, Jiangsu, China.
Jianxin ZhaoState Key Laboratory of Food Science and Technology, Jiangnan University, Wuxi, Jiangsu, China.
Hao ZhangState Key Laboratory of Food Science and Technology, Jiangnan University, Wuxi, Jiangsu, China.
Bo YangState Key Laboratory of Food Science and Technology, Jiangnan University, Wuxi, Jiangsu, China. bo.yang@jiangnan.edu.cn.
Wei ChenState Key Laboratory of Food Science and Technology, Jiangnan University, Wuxi, Jiangsu, China.
Jiangnan University · CNAPC Microbiome Institute · IEState Key Laboratory of Food Science and Technology · CNUniversity College Cork · IEWuxi People's Hospital · CN

Funding

National First-Class Discipline Program of Food Science and Technology JUFSTR20180102National Natural Science Foundation of China Nos.31722041National Natural Science Foundation of China Nos. 31801521National Natural Science Foundation of China Nos.31820103010Postgraduate Research & Practice Innovation Program of Jiangsu Province KYCX19_1829Wuxi Young Talent Foundation QNRC075
6 · The paper itself

Abstract

purposeThe study aimed to investigate the discrepancy and potential mechanisms of different CLA-producing B. breve on dextran sulphate sodium (DSS)-induced colitis.

methodsColitis was induced in C57BL/6 J mice using DSS. Disease activity index (DAI), histopathological changes, epithelial barrier integrity and epithelial apoptosis were determined. Gut microbiota were gauged to evaluate the systemic effects of CLA-producing B. breve.

resultsOral administration of different B. breve showed different effects, in which B. breve M1 and B. breve M2 alleviated the inflammation induced by DSS as well as significantly increased the concentration of mucin2 (MUC2) and goblet cells, but neither B. breve M3 nor B. breve M4 had those protective effects. Meanwhile, B. breve M1 and B. breve M2 treatments significantly up-regulated the tight junction (TJ) proteins and ameliorated the epithelial apoptosis lead by DSS challenge. Moreover, inflammatory cytokines (TNF-α, IL-6) were modulated by B. breve M1 and B. breve M2, neither B. breve M3 nor B. breve M4. Furthermore, B. breve M1 and B. breve M2 reduced the abundance of Bacteroides and increased the abundance of Odoribacter, then rebalanced the damaged gut microbiota. Colonic CLA concentrations in mice fed with B. breve M1, B. breve M2, B. breve M3 and B. breve M4 decreased successively, which showed significant positive correlation with the effectiveness of relieving colitis.

conclusionsBifidobacterium breve M1 and B. breve M2 alleviated DSS-induced colitis by producing CLA, inhibiting the inflammatory cytokines, maintaining of the intestinal epithelial barrier and regulating the gut microbiota.

Indexed as

Bifidobacterium breveColitisGastrointestinal MicrobiomeAnimalsDextran SulfateDisease Models, AnimalIntestinal MucosaMiceMice, Inbred C57BLDextran SulfateBifidobacterium breveColitisConjugated linoleic acidGut microbiotaIntestinal tract barrier

Identifiers

PMID32350653
OpenAlexW3022085588

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.